Detalhe da pesquisa
1.
GLA/DRST real-world outcome analysis of CAR T-cell therapies for large B-cell lymphoma in Germany.
Blood
; 140(4): 349-358, 2022 07 28.
Artigo
Inglês
| MEDLINE | ID: mdl-35316325
2.
Additional cytogenetic features determine outcome in patients allografted for TP53 mutant acute myeloid leukemia.
Cancer
; 128(15): 2922-2931, 2022 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35612815
3.
Treosulfan compared with reduced-intensity busulfan improves allogeneic hematopoietic cell transplantation outcomes of older acute myeloid leukemia and myelodysplastic syndrome patients: Final analysis of a prospective randomized trial.
Am J Hematol
; 97(8): 1023-1034, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35617104
4.
Standardized monitoring of cytomegalovirus-specific immunity can improve risk stratification of recurrent cytomegalovirus reactivation after hematopoietic stem cell transplantation.
Haematologica
; 106(2): 363-374, 2021 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31879324
5.
Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group.
Ann Hematol
; 100(4): 959-968, 2021 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-33191481
6.
CD52-negative T cells predict acute graft-versus-host disease after an alemtuzumab-based conditioning regimen.
Br J Haematol
; 191(2): 253-262, 2020 10.
Artigo
Inglês
| MEDLINE | ID: mdl-32410220
7.
Changes in Immunosuppressive Treatment of Chronic Graft-versus-Host Disease: Comparison of 2 Surveys within Allogeneic Hematopoietic Stem Cell Transplant Centers in Germany, Austria, and Switzerland.
Biol Blood Marrow Transplant
; 25(7): 1450-1455, 2019 07.
Artigo
Inglês
| MEDLINE | ID: mdl-30876928
8.
Diagnosis of sinusoidal obstruction syndrome: can biopsy be the key?
Ann Hematol
; 102(12): 3635-3637, 2023 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37740063
9.
Dermatopathic lymphadenopathy with Langerhans cell chimerism in graft-versus-host disease of the skin.
Eur J Haematol
; 99(6): 582-585, 2017 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-28888027
10.
Correction to: Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group.
Ann Hematol
; 100(8): 2141-2142, 2021 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-34160650
11.
Allogeneic stem cell transplantation for acquired pure red cell aplasia.
Am J Hematol
; 94(11): E294-E296, 2019 11.
Artigo
Inglês
| MEDLINE | ID: mdl-31396977
12.
Treatment of newly diagnosed moderate or severe chronic graft-versus-host disease with prednisone and everolimus (PredEver first): a prospective multicenter phase IIA study.
Bone Marrow Transplant
; 2024 May 02.
Artigo
Inglês
| MEDLINE | ID: mdl-38698080
13.
Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients - A clinical trial to registry data comparison.
Bone Marrow Transplant
; 59(5): 670-679, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38383713
14.
Comparison of fludarabine/melphalan (FluMel) with fludarabine/melphalan/BCNU or thiotepa (FBM/FTM) in patients with AML in first complete remission undergoing allogeneic hematopoietic stem cell transplantation - a registry study on behalf of the EBMT Acute Leukemia Working Party.
Bone Marrow Transplant
; 59(2): 247-254, 2024 02.
Artigo
Inglês
| MEDLINE | ID: mdl-38040842
15.
Validation of the transplant conditioning intensity (TCI) index for allogeneic hematopoietic cell transplantation.
Bone Marrow Transplant
; 59(2): 217-223, 2024 02.
Artigo
Inglês
| MEDLINE | ID: mdl-37978322
16.
Donor KIR genotype based outcome prediction after allogeneic stem cell transplantation: no land in sight.
Front Immunol
; 15: 1350470, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38629074
17.
Remission induction versus immediate allogeneic haematopoietic stem cell transplantation for patients with relapsed or poor responsive acute myeloid leukaemia (ASAP): a randomised, open-label, phase 3, non-inferiority trial.
Lancet Haematol
; 11(5): e324-e335, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38583455
18.
Comparative analysis of CAR T-cell therapy access for DLBCL patients: associated challenges and solutions in the four largest EU countries.
Front Med (Lausanne)
; 10: 1128295, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37324138
19.
Allogeneic hematopoietic stem cell transplantation for NK/T-cell lymphoma: an international collaborative analysis.
Leukemia
; 37(7): 1511-1520, 2023 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37157017
20.
CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trial.
Nat Med
; 29(11): 2844-2853, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-37872225